Drug Profile
CB 1001
Alternative Names: Cancer vaccine - Cosmo Pharmaceuticals; CB-10-01; TLILatest Information Update: 03 Dec 2021
Price :
$50
*
At a glance
- Originator Cosmo Pharmaceuticals
- Class Cancer vaccines
- Mechanism of Action Immunostimulants; Telomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malignant melanoma; Prostate cancer
Most Recent Events
- 08 Jul 2009 Phase-II development is ongoing in USA
- 03 May 2005 Phase-II clinical trials in Prostate cancer in USA (Infusion)
- 09 Jun 2004 Preclinical trials in Solid tumours in USA (Infusion)